To date, the studies that have characterized the course of diabetes in WFS patients have shown inconsistent results concerning the degree of metabolic control (based on HbA1c level) and insulin requirement in comparison with T1D patients [14, 15]. The gene discussed is INS; the disease is type 1 diabetes mellitus.